Literature DB >> 7017013

Mechanisms of action of the antimycotic imidazoles.

I J Sud, D S Feingold.   

Abstract

The mechanism of the antifungal action of the imidazole antimycotics, miconazole ano clotrimazole, on Saccharomyces cerevisiae was explored. When grown aerobically both drugs were fungistatic at low concentrations and fungicidal at high concentrations. When grown anaerobically the fungistatic effect was not seen, but killing still occurred at high concentrations. The fungistatic effect correlated with inhibition of ergosterol synthesis and elevated lanosterol/ergosterol ratios in the organisms. The fungicidal effect involved rapid membrane damage and was unrelated to the imidazole-induced block in ergosterol synthesis. These agents each have 2 distinct antifungal actions.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7017013     DOI: 10.1111/1523-1747.ep12521036

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  29 in total

Review 1.  Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance.

Authors:  M A Ghannoum; L B Rice
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

2.  Antiproliferative effects and mechanism of action of ICI 195,739, a novel bis-triazole derivative, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi.

Authors:  J A Urbina; K Lazardi; T Aguirre; M M Piras; R Piras
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

3.  Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi.

Authors:  K Lazardi; J A Urbina; W de Souza
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

4.  Structure-based virtual screening and ADME/T-based prediction analysis for the discovery of novel antifungal CYP51 inhibitors.

Authors:  Bin Sun; Hong Zhang; Min Liu; Zhuang Hou; Xinyong Liu
Journal:  Medchemcomm       Date:  2018-06-11       Impact factor: 3.597

5.  Growth phase in relation to ketoconazole and miconazole susceptibilities of Candida albicans.

Authors:  W H Beggs
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

6.  Comparison of terbinafine and clotrimazole in treating tinea pedis.

Authors:  E G Evans; B Dodman; D M Williamson; G J Brown; R G Bowen
Journal:  BMJ       Date:  1993-09-11

7.  Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole.

Authors:  A Casadevall; E D Spitzer; D Webb; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

8.  Effect of ketoconazole on the fungicidal action of amphotericin B in Candida albicans.

Authors:  I J Sud; D S Feingold
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

9.  Action of antifungal imidazoles on Staphylococcus aureus.

Authors:  I J Sud; D S Feingold
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

10.  A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis.

Authors:  N V Prajna; R K John; P K Nirmalan; P Lalitha; M Srinivasan
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.